First Bank & Trust Emergent Bio Solutions Inc. Transaction History

First Bank & Trust

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$27.42 - $43.63 $6,964 - $11,082	-254 Reduced 12.09%	1,847 $57,000
Q1 2022 Apr 29, 2022	BUY	$36.48 - $52.22 $9,156 - $13,107	251 Added 13.57%	2,101 $86,000
Q4 2021 Feb 01, 2022	BUY	$33.11 - $55.01 $14,965 - $24,864	452 Added 32.33%	1,850 $81,000
Q2 2021 Aug 10, 2021	SELL	$56.61 - $80.46 $30,852 - $43,850	-545 Reduced 28.05%	1,398 $88,000
Q1 2021 Apr 14, 2021	BUY	$86.23 - $125.19 $29,576 - $42,940	343 Added 21.44%	1,943 $181,000
Q4 2020 Jan 27, 2021	SELL	$79.17 - $111.47 $52,964 - $74,573	-669 Reduced 29.48%	1,600 $143,000
Q3 2020 Oct 26, 2020	SELL	$81.91 - $134.94 $64,381 - $106,062	-786 Reduced 25.73%	2,269 $234,000
Q2 2020 Aug 05, 2020	BUY	$54.33 - $89.52 $70,357 - $115,928	1,295 Added 73.58%	3,055 $242,000
Q1 2020 Apr 14, 2020	BUY	$49.34 - $68.76 $35,080 - $48,888	711 Added 67.78%	1,760 $102,000
Q4 2019 Jan 31, 2020	BUY	$51.21 - $59.06 $49,264 - $56,815	962 Added 1105.75%	1,049 $57,000
Q2 2019 Jul 26, 2019	BUY	$39.92 - $53.86 $3,473 - $4,685	87 New	87 $4,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $442M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of First Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on First Bank & Trust with notifications on news.